Advertisement
UK markets open in 7 hours 3 minutes
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.44
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,337.40
    -4.70 (-0.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • Bitcoin GBP

    53,329.40
    -364.96 (-0.68%)
     
  • CMC Crypto 200

    1,429.91
    +15.15 (+1.07%)
     
  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

Primary Health Properties Full Year 2022 Earnings: EPS Misses Expectations

Primary Health Properties (LON:PHP) Full Year 2022 Results

Key Financial Results

  • Revenue: UK£154.1m (up 5.8% from FY 2021).

  • Net income: UK£56.3m (down 60% from FY 2021).

  • Profit margin: 37% (down from 96% in FY 2021).

  • EPS: UK£0.042 (down from UK£0.10 in FY 2021).

PHP Net Asset Value

  • Net asset value (NAV) per share: UK£1.11 (down 1.4% from FY 2021).

    • The current share price is 5.5% lower than NAV per share.

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Primary Health Properties EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 68%.

ADVERTISEMENT

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 2.8% growth forecast for the REITs industry in the United Kingdom.

Performance of the British REITs industry.

The company's shares are up 2.7% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Primary Health Properties (1 is potentially serious) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here